In their division, NMIBC is classified more frequently as a luminal molecular subtype with the morphology of conventional urothelial carcinoma and usually low PD-L1 expression as well as high GATA3 or KRT20 messenger RNA (mRNA) levels. The gene discussed is CD274; the disease is urothelial carcinoma.